Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis
- 21 September 2015
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Molecular Diagnostics
- Vol. 15 (11) , 1491-1504
Abstract
(2015). Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis. Expert Review of Molecular Diagnostics: Vol. 15, No. 11, pp. 1491-1504.Keywords
This publication has 75 references indexed in Scilit:
- RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasisNature, 2012
- A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarkerBritish Journal of Cancer, 2011
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerNew England Journal of Medicine, 2011
- Distant metastasis occurs late during the genetic evolution of pancreatic cancerNature, 2010
- The patterns and dynamics of genomic instability in metastatic pancreatic cancerNature, 2010
- Isolation of circulating tumor cells using a microvortex-generating herringbone-chipProceedings of the National Academy of Sciences, 2010
- Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT–PCR in patients with metastatic breast cancerBritish Journal of Cancer, 2009
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic AnalysesScience, 2008
- Isolation of rare circulating tumour cells in cancer patients by microchip technologyNature, 2007
- Multistep Nature of Metastatic InefficiencyThe American Journal of Pathology, 1998